Rights and permissions
About this article
Cite this article
Etoposide 3- or 21-day regimen QOL effect in SCLC. Pharmacoecon. Outcomes News 368, 10 (2002). https://doi.org/10.1007/BF03279239
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279239